Table 2.
No UR (n=60) |
UR (n=30) |
p | |
---|---|---|---|
Age, mean ± SD (years) | 53.0 ± 16.1 | 53.7 ± 13.1 | 0.83 |
FEV1, mean ± SD (% predicted) | 35.4 ± 16.6 | 34.6 ± 18.9 | 0.85 |
Male sex, n (%) | 34 (56.7) | 17 (56.7) | 1.00 |
Pulmonary fibrosis, n (%) | 30 (50.0) | 22 (73.3) | 0.04 |
Concern about social support, n (%) | 12 (20.0) | 5 (16.7) | 0.78 |
Six minute walk test, mean ± SD (feet) | 923.4 ± 412.7 | 1007.2 ± 429.2 | 0.38 |
Number of hospitalizations in year prior to transplantation, median (IQR) | 1 (0-2) | 0 (0-2) | 0.52 |
SPPB<8 at transplant listing, n (%) | 12 (20.3) | 9 (20.0) | 0.43 |
Lung allocation score >50 | 14 (23.3) | 12 (40.0) | 0.14 |
Cytomegalovirus donor positive recipient negative, n (%) | 20 (33.3) | 7 (23.3) | 0.46 |
Any grade 3 primary graft dysfunction, n (%) | 7 (11.7) | 5 (16.7) | 0.52 |
Acute kidney injury during index hospitalization, n (%) | 31 (51.7) | 11 (36.7) | 0.26 |
Intensive care unit length of stay, median (IQR) (days) | 7 (4-13) | 5 (3-15) | 0.66 |
Index hospitalization length of stay, median (IQR) (days) | 17 (13-22) | 21 (13-26) | 0.32 |
SPPB<6 on discharge, n (%) | 37 (61.7) | 26 (86.7) | 0.02 |
SPPB at discharge, median (IQR) | 5 (4-6) | 4 (4-5) | 0.28 |
A-state score at discharge, median (IQR) | 38 (26-45) | 35 (27-46) | 0.82 |
A-trait score at discharge, median (IQR) | 33 (25-41) | 33 (25-41) | 0.97 |
Initial discharge to LTACH or rehabilitation facility, n (%) | 16 (26.7) | 5 (16.7) | 0.43 |
FEV1, forced expiratory volume in 1 second; IQR, interquartile range; LTACH, long term acute care hospital; SPPB, short performance physical battery; SD, standard deviation; UR, unplanned rehospitalization